Myristoleic acid

Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apoptosis and necrosis in human prostatic LNCaP cells[1].

Product Specifications

CAS Number

[544-64-9]

Product Name Alternative

PD-189659

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Endogenous Metabolite

Type

Natural Products

Related Pathways

Apoptosis; Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/myristoleic-acid.html

Concentration

10mM

Purity

98.0

Solubility

Ethanol : ≥ 100 mg/mL

Smiles

CCCC/C=C\CCCCCCCC(O)=O

Molecular Formula

C14H26O2

Molecular Weight

226.36

Precautions

H302, H315, H319, H335

References & Citations

[1]Xiaoyan Gao, et al. Ozone initiated heterogeneous oxidation of unsaturated carboxylic acids by ATR-FTIR spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2019 May 5;214:177-183.|[2]Jun-Oh Kwon, et al. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2. Eur J Pharmacol. 2015 Dec 5;768:189-98.